enow.com Web Search

  1. Ads

    related to: current treatment for ankylosing spondylitis
  2. wexnermedical.osu.edu has been visited by 10K+ users in the past month

    262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464

Search results

  1. Results from the WOW.Com Content Network
  2. Ankylosing spondylitis - Wikipedia

    en.wikipedia.org/wiki/Ankylosing_spondylitis

    Non-TNFi "biologic" drugs used in the treatment of ankylosing spondylitis include drugs that target different pathways involved in the inflammatory process. Two of the most important drugs in this class target IL-17, an important part of the inflammatory system: secukinumab and ixekizumab. They are often considered in cases where TNFi drugs are ...

  3. Tofacitinib - Wikipedia

    en.wikipedia.org/wiki/Tofacitinib

    Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis. [8] [9] [10] It is a janus kinase (JAK) inhibitor, [8] [9] discovered and developed by the National Institutes of ...

  4. Bimekizumab - Wikipedia

    en.wikipedia.org/wiki/Bimekizumab

    Bimekizumab, sold under the brand name Bimzelx, is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody [6] [7] that is used to treat plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis and hidradenitis suppurativa.

  5. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    rheumatoid arthritis, Crohn's disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, hemolytic disease of the newborn: Adecatumumab [9] mab: human: EpCAM: prostate and breast cancer: Aducanumab [10] Aduhelm: mab: human: Amyloid beta: Y [11] Alzheimer's disease: Afasevikumab [12] mab: human: IL-17A ...

  6. BASDAI - Wikipedia

    en.wikipedia.org/wiki/BASDAI

    The BASDAI or Bath Ankylosing Spondylitis Disease Activity Index is a validated diagnostic test which allows a physician, usually a rheumatologist, to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of Ankylosing spondylitis (AS).

  7. ‘My Low Back Pain Turned Out To Be A Rare Inflammatory ...

    www.aol.com/low-back-pain-turned-rare-120000344.html

    I thought I was all alone with my condition, but there are approximately 300,000 Canadians who have ankylosing spondylitis, per the Arthritis Society of Canada, and an estimated 1.7 million adults ...

  1. Ads

    related to: current treatment for ankylosing spondylitis